BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27601173)

  • 1. Proteomic Analysis of Parkin Isoforms Expression in Different Rat Brain Areas.
    D'Amico AG; Maugeri G; Reitano R; Cavallaro S; D'Agata V
    Protein J; 2016 Oct; 35(5):354-362. PubMed ID: 27601173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain.
    Scuderi S; La Cognata V; Drago F; Cavallaro S; D'Agata V
    Biomed Res Int; 2014; 2014():690796. PubMed ID: 25136611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-3-3eta is a novel regulator of parkin ubiquitin ligase.
    Sato S; Chiba T; Sakata E; Kato K; Mizuno Y; Hattori N; Tanaka K
    EMBO J; 2006 Jan; 25(1):211-21. PubMed ID: 16096643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and distribution of Parkin in rat brain.
    Horowitz JM; Myers J; Stachowiak MK; Torres G
    Neuroreport; 1999 Nov; 10(16):3393-7. PubMed ID: 10599851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of PARK2 splice isoforms in an in vitro model of dopaminergic-like neurons exposed to toxic insults mimicking Parkinson's disease.
    La Cognata V; Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
    J Cell Biochem; 2018 Jan; 119(1):1062-1073. PubMed ID: 28688199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcine Parkin: molecular cloning of PARK2 cDNA, expression analysis, and identification of a splicing variant.
    Bjerre D; Madsen LB; Bendixen C; Larsen K
    Biochem Biophys Res Commun; 2006 Sep; 347(3):803-13. PubMed ID: 16844087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin expression in the adult mouse brain.
    Stichel CC; Augustin M; Kühn K; Zhu XR; Engels P; Ullmer C; Lübbert H
    Eur J Neurosci; 2000 Dec; 12(12):4181-94. PubMed ID: 11122330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model.
    Klein RL; Dayton RD; Henderson KM; Petrucelli L
    Neurosci Lett; 2006 Jun; 401(1-2):130-5. PubMed ID: 16554120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease.
    Fukae J; Sato S; Shiba K; Sato K; Mori H; Sharp PA; Mizuno Y; Hattori N
    FEBS Lett; 2009 Feb; 583(3):521-5. PubMed ID: 19146857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The KM-parkin-DB: A Sub-set MutationView Database Specialized for PARK2 (PARKIN) Variants.
    Mitsuyama S; Ohtsubo M; Minoshima S; Shimizu N
    Hum Mutat; 2015 Aug; 36(8):E2430-40. PubMed ID: 25907632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of parkin isoforms in lung adenocarcinomas.
    D'Amico AG; Maugeri G; Magro G; Salvatorelli L; Drago F; D'Agata V
    Tumour Biol; 2015 Jul; 36(7):5133-41. PubMed ID: 25656612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile of parkin isoforms in human gliomas.
    Maugeri G; D'Amico AG; Magro G; Salvatorelli L; Barbagallo GM; Saccone S; Drago F; Cavallaro S; D'Agata V
    Int J Oncol; 2015 Oct; 47(4):1282-92. PubMed ID: 26238155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RING finger 1 mutations in Parkin produce altered localization of the protein.
    Cookson MR; Lockhart PJ; McLendon C; O'Farrell C; Schlossmacher M; Farrer MJ
    Hum Mol Genet; 2003 Nov; 12(22):2957-65. PubMed ID: 14519684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.
    Fiesel FC; Caulfield TR; Moussaud-Lamodière EL; Ogaki K; Dourado DF; Flores SC; Ross OA; Springer W
    Hum Mutat; 2015 Aug; 36(8):774-86. PubMed ID: 25939424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkin transcript variants in rat and human brain.
    Dagata V; Cavallaro S
    Neurochem Res; 2004 Sep; 29(9):1715-24. PubMed ID: 15453267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y: identification of a novel rat mRNA splice-variant that is downregulated in the hippocampus and the prefrontal cortex of a depression-like model.
    Melas PA; Mannervik M; Mathé AA; Lavebratt C
    Peptides; 2012 May; 35(1):49-55. PubMed ID: 22406386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
    Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
    Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial distribution, cellular integration and stage development of Parkin protein in Xenopus brain.
    Horowitz JM; Myers J; Vernace VA; Stachowiak MK; Torres G
    Brain Res Dev Brain Res; 2001 Jan; 126(1):31-41. PubMed ID: 11172884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of rat parkin cDNA and distribution of parkin in rat brain.
    Gu WJ; Abbas N; Lagunes MZ; Parent A; Pradier L; Bohme GA; Agid Y; Hirsch EC; Raisman-Vozari R; Brice A
    J Neurochem; 2000 Apr; 74(4):1773-6. PubMed ID: 10737637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin and synphilin-1 isoform expression changes in Lewy body diseases.
    Humbert J; Beyer K; Carrato C; Mate JL; Ferrer I; Ariza A
    Neurobiol Dis; 2007 Jun; 26(3):681-7. PubMed ID: 17467279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.